Please assess the completion status of the following clinical trial:

Trial Title: Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 29-77 years; have lived in Pasto, Colombia for at least 5 years and plan to remain in Pasto for ≥5 more years;~* Currently have Helicobacter pylori infection;~* Willing to refrain from alcohol consumption for 2 weeks;~* Have never taken a therapy to eradicate Helicobacter pylori;~* Have not taken antibiotics, bismuth compounds, proton-pump inhibitors, H2-receptor antagonists, or antacids within 30 days of the trial;~* Are not pregnant, and have little or no risk of pregnancy.~Exclusion Criteria:~* History of kidney, liver, heart, or mental disease;~* Frequent alcohol consumption;~* Allergic to clarithromycin, amoxicillin, penicillin, omeprazole or metronidazole;~* Currently taking drugs which may interact with any of the trial medications.

- Gender: ALL
- Minimum Age: 29 Years
- Maximum Age: 77 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Clarithromycin 500 mg bid, metronidazole 500 mg tid, and amoxicillin 500mg tid for 14 days (with or without omeprazole 20 mg bid)
- 2 (Type: ACTIVE_COMPARATOR): Clarithromycin 500 mg bid, amoxicillin 1 g bid, and omeprazole 20 mg bid for 10 days

Based on this trial design, predict the completion outcome and termination type (if applicable).